New Issue: Orbital Catastrophe Ahead? Read Now

Bio-Spleen Sucks Pathogens and Toxins from Blood

The new device rids the blood of bacteria, fungi, viruses and toxins using nanoscale-size magnetic beads. Cynthia Graber reports

Illustration of a Bohr atom model spinning around the words Science Quickly with various science and medicine related icons around the text

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Sepsis is a potentially deadly inflammatory condition caused by infections. Muppet creator Jim Henson was a famous victim. Proper treatment of sepsis can require knowing what bacteria or virus caused the infection. But the identification can take days, and by that time it’s often too late. Some eight million people die of sepsis annually worldwide.

Now, scientists at Harvard’s Wyss Institute of Biologically Inspired Engineering have come up with a device that cleans blood—without a need to diagnose the infectious agent. What’s being called the bio-spleen seems to work even for antibiotic-resistant bacteria.

In the device, blood is cycled outside the patient’s body and gets filtered through microfluidic channels. The channels nanoscale-sized magnetic beads attached to an immune system protein. The protein naturally latches onto bacteria, fungi, viruses, and toxins.

Then magnets pull the magnetic beads out of the blood, taking the attached pathogens and toxins along for the ride. The cleansed blood then flows back into the patient.

The researchers tested the system on human blood, and then on infected rats. In the trial, 90 percent of the treated rats recovered. Only 14 percent of the controls survived. The research is in the journal Nature Medicine. [Joo H. Kang et al, An extracorporeal blood-cleansing device for sepsis therapy]

The scientists hope to quickly scale up to human trials and ultimately develop a version that could find a place in the emergency room armamentarium.

—Cynthia Graber

[The above text is a transcript of this podcast.]

[Scientific American is part of Nature Publishing Group.]

Cynthia Graber is a print and radio journalist who covers science, technology, agriculture, and any other stories in the U.S. or abroad that catch her fancy. She's won a number of national awards for her radio documentaries, including the AAAS Kavli Science Journalism Award, and is the co-host of the food science podcast Gastropod. She was a Knight Science Journalism fellow at MIT.

More by Cynthia Graber

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe